quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:47:17·43d
INSIDERFiling
Bicara Therapeutics Inc. logo

SEC Form 4 filed by Bicara Therapeutics Inc.

BCAX· Bicara Therapeutics Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • BCAX
    Bicara Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 25UpdateBofA Securities$35.00
  • Jan 29UpdateCitizens JMP$31.00
  • Jan 8UpdateBTIG Research$28.00
  • Dec 18UpdateMizuho$18.00
  • Aug 19UpdatePiper Sandler$36.00
  • May 23UpdateWells Fargo$8.00

Related

  • INSIDER1d
    SEC Form 4 filed by Hyep Ivan
  • INSIDER3d
    SEC Form 4 filed by Mazumdar Claire
  • SEC3d
    SEC Form 144 filed by Bicara Therapeutics Inc.
  • INSIDER6d
    SEC Form 4 filed by Cohlhepp Ryan
  • SEC15d
    Amendment: SEC Form SCHEDULE 13G/A filed by Bicara Therapeutics Inc.
  • PR20d
    Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
  • SEC24d
    SEC Form 10-K filed by Bicara Therapeutics Inc.
  • SEC24d
    Bicara Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022